Amy L. Jonson

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

Melissa A. Geller, Sarah Cooley, Patricia L. Judson et al. · Cytotherapy · 2010 · 426 citations · Full text

Breast Oncology, Medicine, Immunology +10

A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer

Peter A. Argenta, Sajeena G. Thomas, Patricia L. Judson et al. · Gynecologic Oncology · 2009 · 86 citations

Medicine, Gynecology, Pathology +6

A prospective, randomized study analyzing sartorius transposition following inguinal–femoral lymphadenectomy

Patricia L. Judson, Amy L. Jonson, Pamela J. Paley et al. · Gynecologic Oncology · 2004 · 82 citations

Medicine, Surgery, Orthopaedic Surgery +1

Clinical features and outcomes of uterine and ovarian carcinosarcoma

Amy L. Jonson, Robin Bliss, Alexander M. Truskinovsky et al. · Gynecologic Oncology · 2005 · 68 citations

Gynecological Surgery, Medicine, Clinical Features +4

A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a “Sandwich” method for stage III, IV, and recurrent endometrial cancer

Melissa A. Geller, Joseph J. Ivy, Rahel Ghebre et al. · Gynecologic Oncology · 2011 · 65 citations · Full text

Phase Ii Trial, Radiation Therapy, Medicine +7